Crossmark

Ultrabright contrast agents with synergistic Raman enhancements for precise intraoperative imaging and photothermal ablation of orthotopic tumor models

Crossref DOI link: https://doi.org/10.1186/s12951-025-03099-2

Published Online: 2025-01-19

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ma, Yiqun

Xia, Shuchi

Hu, Annan

Zhang, Qianyi

Shao, Zhengzhong

Tian, Bo

Lin, Qinrui
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (82003279)

National Natural Science Foundation of China (22105044)
License Information

Text and Data Mining valid from 2025-01-19

Version of Record valid from 2025-01-19
More Information

Article History

Received: 8 August 2024

Accepted: 7 January 2025

First Online: 19 January 2025

Declarations

:

: All animal experiments conducted in this study were performed in accordance with the guidelines and regulations set by Fudan University. All animal experimental procedures were approved by the Ethic Committee of Fudan University (approval number: FE21067).

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below